Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Their purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases.
Transformational technologies in type 2 diabetes: CGM and connected insulin pens
This advanced course will take you on an illuminating journey into data-driven type 2 diabetes management involving continuous glucose monitoring (CGM) and connected insulin pens, with an opportunity to practically engage with the technology and data that can change our patients’ lives.
Diabetes cycle of care quality improvement program (Practice staff version)
This is a whole practice quality improvement (QI) program for GP practices, based on the annual diabetes cycle of care for patients with T2D.
Diabetes cycle of care quality improvement program (GP version)
This is a whole practice quality improvement (QI) program for GP practices, based on the annual diabetes cycle of care for patients with T2D.
Diabetes cycle of care quality improvement program
This is a whole practice quality improvement (QI) program for GP practices, based on the annual diabetes cycle of care for patients with T2D.
